GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Total Stockholders Equity

Zura Bio (STU:94E) Total Stockholders Equity : €127.84 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Zura Bio Total Stockholders Equity?

Zura Bio's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €127.84 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Zura Bio's Book Value per Share for the quarter that ended in Mar. 2025 was €1.87. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Zura Bio's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.00.

Zura Bio Total Stockholders Equity Historical Data

The historical data trend for Zura Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio Total Stockholders Equity Chart

Zura Bio Annual Data
Trend Mar22 Dec23 Dec24
Total Stockholders Equity
-7.10 54.41 140.21

Zura Bio Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.13 145.41 137.89 140.21 127.84

Zura Bio  (STU:94E) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Zura Bio's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(127.835-0)/68.375
=1.87

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Zura Bio's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 127.835
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zura Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zura Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zura Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Total Stockholders Equity
Comparable Companies
XCUR OKYO TELO CNTX ABOS NTRB IRD MGX UNCY VANI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ZURA:USA
Address
1489 W. Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
Website
https://www.zurabio.com
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Zura Bio Headlines

No Headlines